An Innovative Disease-Drug-Trial Framework to Guide Binge Eating Disorder Drug Development: A Case Study for Topiramate.

Clinical and Translational Science
Shamir N KalariaMathangi Gopalakrishnan

Abstract

As with other psychiatric disorders, development of drugs to treat binge-eating disorder (BED) has been hampered by high placebo response and dropout rates in randomized controlled trials (RCTs). Although not approved for use in BED, several RCTs have suggested that topiramate is efficacious for BED in obese individuals. Using data from a positive investigator-initiated RCT of topiramate in 61 obese individuals with BED, the objective of the present study is (i) to develop a quantitative disease-drug-trial framework to inform future BED clinical trial designs, and (ii) to determine the optimal topiramate dose to achieve therapeutic efficacy. Disease-drug-trial models were developed separately for the two efficacy measures, namely, longitudinal normalized weekly binge-eating episode frequency (BEF) and binge day frequency (BDF). Model building consisted of (i) developing a placebo effect model that describes response from the placebo group, (ii) adding a drug effect to the placebo model to describe dose-response relationships, and (iii) developing a parametric time to event model to characterize patient dropout patterns. The placebo effect on normalized BEF and BDF over time demonstrated a maximum decrease of ~ 57% by 5 weeks. P...Continue Reading

References

Aug 26, 1995·BMJ : British Medical Journal·E Ernst, K L Resch
Feb 4, 2003·The American Journal of Psychiatry·Susan L McElroyJames I Hudson
Nov 24, 2004·The Journal of Clinical Psychiatry·Susan L McElroyJames I Hudson
Dec 16, 2005·The AAPS Journal·Pravin R Jadhav, Jogarao V S Gobburu
Jul 4, 2006·Biological Psychiatry·James I HudsonRonald C Kessler
Jan 30, 2007·Biological Psychiatry·Susan L McElroyUNKNOWN Topiramate Binge Eating Disorder Research Group
Oct 6, 2007·The Journal of Clinical Psychiatry·Angélica M ClaudinoJosué Bacaltchuk
Oct 15, 2008·Annual Review of Pharmacology and Toxicology·Jogarao V S Gobburu, Lawrence J Lesko
Apr 30, 2009·The International Journal of Eating Disorders·Silja VocksStephan Herpertz
Jun 10, 2011·Clinical Pharmacokinetics·Venkatesh Pilla ReddyJohannes H Proost
Oct 4, 2011·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Martin AignerUNKNOWN WFSBP Task Force On Eating Disorders
Mar 13, 2012·Pharmaceutical Statistics·Xu Steven XuPartha Nandy
Oct 12, 2012·Science Translational Medicine·Steven E Hyman
Jan 3, 2013·JAMA : the Journal of the American Medical Association·Katherine M FlegalBarry I Graubard
Mar 5, 2013·Journal of Pharmacokinetics and Pharmacodynamics·Wan SunYaning Wang
Sep 10, 2014·The International Journal of Eating Disorders·Andrew GrotzingerJessica Yu
Mar 23, 2015·Current Psychiatry Reports·Susan L McElroyPaul E Keck
Jun 5, 2015·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Thomas R Insel
Jan 27, 2017·The Journal of Clinical Psychiatry·Susan L McElroy
Sep 2, 2017·The American Journal of Psychiatry·Stephen R MarderSteven J Romano
Jul 28, 2018·The International Journal of Eating Disorders·Julian R BautistaAdvait Rajagopal

❮ Previous
Next ❯

Citations

Nov 13, 2019·Expert Opinion on Investigational Drugs·Jose C AppolinarioSusan L McElroy
Feb 6, 2020·Frontiers in Endocrinology·Carolyn T BramanteJustin R Ryder

❮ Previous
Next ❯

Software Mentioned

R
Phoenix NLME

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition
Cherry Wyant JacksonRaymond Lorenz
© 2021 Meta ULC. All rights reserved